pharma news

News

Digital osteoarthritis, bulimia tools backed for NHS use

Guidance in the UK has cleared the way for NHS use of digital health technologies for people with osteoarthritis and eating disorder bulimia.

News

Sanofi plans amlitelimab dermatitis filing after new readout

Sanofi has said it will press ahead with regulatory filings for atopic dermatitis candidate amlitelimab, despite mixed data in phase 3.

News

Corxel's raises $287m for obesity drug, and other financings

Our latest biofinancing round-up sees big rounds for Corxel and Caldera, with Mendra, Think Bio, Exciva, Cytotheryx, and Infinitopes also raising cash

News

Change of heart as NICE backs prostate cancer drug Talzenna

Thousands of men with prostate cancer will be offered a new treatment, Pfizer's Talzenna, after NICE made an about-turn on the drug.

News

Ovarian cancer data restores faith in Corcept's relacorilant

After Corcept's setback with relacorilant in Cushing syndrome last month, the company has bounced back with strong survival data in ovarian cancer.

News

J&J says 2026 sales could top $100 billion

J&J says its sales should top $100 billion this year, as it pushes its oncology business towards a target of $50 billion by the end of the decade.

Digital osteoarthritis, bulimia tools backed for NHS use

Sanofi plans amlitelimab dermatitis filing after new readout

Corxel's raises $287m for obesity drug, and other financings

Change of heart as NICE backs prostate cancer drug Talzenna

Ovarian cancer data restores faith in Corcept's relacorilant

J&J says 2026 sales could top $100 billion

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

pharma news

Editor's Picks